Inhibition of FoxQ1 in glioma cells by transfection of FoxQ1 shRNA significantly up-regulated NRXN3 expression and reduced the ability of proliferation and migration in glioma cells, whereas overexpression of a FoxQ1 expression vector did the opposite. The gene discussed is NRXN3; the disease is central nervous system cancer.